期刊文献+

iPSC-MSCs抑制ApoE(-/-)小鼠动脉粥样硬化斑块形成及其机制 被引量:1

Inhibitory effect of iPSC-MSCs on atherosclerotic plaque formation in Apo E(-/-) mice and its mechanism
原文传递
导出
摘要 目的探究诱导性多能干细胞源性间充质干细胞(iPSC-MSCs)对高脂饲养的ApoE(-/-)小鼠的动脉粥样硬化抑制作用及其相关机制。方法 40只8周的ApoE-/-小鼠随机分为4组,每组10只:普通饲料组:给予普通饲料喂养,高脂饲料组:给予高脂饲料喂养,干细胞组:给予高脂喂养同时尾静脉注射iPSC-MSCs,PBS组:给予高脂喂养同时尾静脉注射PBS。12周后观察小鼠主动脉粥样硬化斑块形成情况、血脂水平、炎症因子水平以及Nothc1蛋白的表达情况。结果高脂喂养后,高脂组ApoE(-/-)小鼠的斑块面积较普通饲料组明显增多,且小鼠总胆固醇(CHOL)、低密度脂蛋白(LDL)、TNF-α、IL-6分别为(32.02±2.32)mmol/L、(20.36±0.90)mmol/L、(534.30±89.51)pg/ml、(32.69±1.86)pg/ml均较普通饲料组明显升高,差异具有统计学意义(P<0.01);注射iPSC-MSCs后斑块面积明显减小,小鼠的CHOL、LDL、TNF-α、IL-6水平分别为(24.98±1.18)mmol/L、(15.34±1.54)mmol/L、(230.6±13.31)pg/ml、(8.54±2.02)pg/ml,较高脂组明显下降,差异具有统计学意义(P<0.05)。且高脂组中ApoE(-/-)小鼠的Notch1蛋白水平要明显高于普通饲料组(P<0.01),iPSC-MSCs干预后Notch1蛋白表达水平要明显低于高脂组(P<0.05),PBS对于ApoE(-/-)小鼠Notch1蛋白表达无影响(P>0.05)。结论 iPSC-MSC可以抑制ApoE(-/-)小鼠动脉粥样硬化斑块形成,可能与iPSC-MSCs可以减轻ApoE(-/-)小鼠TNF-a、IL-6等炎症因子水平,降低胆固醇含量,下调Notch1的蛋白表达有关。 Objective This study is to investigate whether mesenchymal stem cells derived from induced pluripotent stemcells(iPSC-MSCs)could alleviate atherosclerosis and its possible modulating mechanism in high-fat fed ApoE(-/-)mice.Methods 40 8-week old ApoE(-/-)mice were divided into four groups. Regular diet group:10 mice were fed withregular diet. High fat diet(HFD)group:10 mice were fed with high fat diet. iPSC-MSCs group :iPSC-MSCs wereintravenously administered to ApoE-/-mice fed on a HFD. PBS group :PBS was intravenously administered to ApoE(-/-)mice fed on a HFD. After 12 weeks,aortas and serum were obtained from ApoE(-/-) mice to detect the sizes ofatherosclerotic plaques,lipid levels,cytokines levels and the expression of Notch1. Results After fed with HFD,the ApoE(-/-)mice in HFD group have larger plaque size than RD group. What's more,the total cholesterol、LDL、TNF-α、IL-6concentrations are(32.02±2.32)mmol/L、(20.36±0.90)mmol/L、(534.30±89.51)pg/ml、(32.69±1.86)pg/ml,which are allhigher than those in RD group(P〈0.01). Systematically administering iPSC-MSCs clearly reduced the size of plaques.Thetotal cholesterol、LDL、TNF-α、IL-6 concentrations are(24.98±1.18)mmol/L、(15.34±1.54)mmol/L、(230.60±13.31)pg/ml、(8.54±2.02)pg/ml,which are all lower than those in HFD group(P〈0.05). In addition,the expression of Notch1 protein inHFD group is higher than that in RD group(P〈0.01). after injecting iPSC-MSCs,we found that the the expression of Notch1 protein were down-regulated(P〈0.05),PBS has no effect on Notch1 protein(P〉0.05). Conclusion Systemicallyadministration of iPSC-MSCs suppressed the atherosclerotic lesions in ApoE(-/-)mice,which was probably related to thereduction of inflammatory cytokines,amelioration of lipid disorder and down-regulation of Notch signaling pathway.
出处 《热带医学杂志》 CAS 2017年第4期452-455,499,共5页 Journal of Tropical Medicine
基金 广东省自然科学基金(2014A030313206)
关键词 iPSC-MSCs 动脉粥样硬化 炎症反应 NOTCH1 iPSC-MSCs Atherosclerosis Inflammatory responses Notch1
  • 相关文献

参考文献1

二级参考文献22

  • 1Go AS,Mozaffarian D,Roger VL,et al.Executive summary:heart disease and stroke statistics--2014 update:a report from the American Heart Association[J].Circulation,2014,129(3):399-410.
  • 2Legein B,Temmerman L,Biessen EA,et al.Inflammation and immune system interactions in atherosclerosis[J].Cell Mol Life Sci,2013,70(20):3847-3869.
  • 3Zeller I,Srivastava S.Macrophage functions in atherosclerosis[J].Circ Res,2014,115(12):e83-e85.
  • 4Lian Q,Zhang Y,Zhang J,et al.Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice[J].Circulation,2010,121(9):1113-1123.
  • 5Fu QL,Chow YY,Sun SJ,et al.Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis[J].Allergy,2012,67(10):1215-1222.
  • 6Sun YQ,Deng MX,He J,et al.Human pluripotent stem cellderived mesenchymal stem cells prevent allergic airway inflammation in mice[J].Stem Cells,2012,30(12):2692-2699.
  • 7Hu X,Chung AY,Wu I,et al.Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways[J].Immunity,2008,29(5):691-703.
  • 8Gazdic M,Volarevic V,Arsenijevic N,et al.Mesenchymal stem cells:a friend or foe in immune-mediated diseases[J].Stem Cell Rev,2015,11(2):280-287.
  • 9Wang ZX,Wang CQ,Li XY,et al.Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25(+)FOXP3(+)regulatory T-cells and inhibiting macrophage foam cell formation[J].Mol Cell Biochem,2015,400(1-2):163-172.
  • 10de Gaetano M,Alghamdi K,Marcone S,et al.Conjugated linoleic acid induces an atheroprotective macrophage MPhi2phenotype and limits foam cell formation[J].J Inflamm(Lond),2015,12:15.

共引文献1

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部